Viveve Medical Inc. (VIVMF) 0.5400 $VIVMF
InsiderInsights.com Daily Round Up 5/14/15: GRPN, AVID, P, MAC
InsiderInsights - at Seeking Alpha - Fri May 15, 9:06AM CDT
LIFE: 20.13 (-0.45), EMES: 37.97 (+1.38), COLL: 15.62 (+0.72), PMCS: 8.44 (-0.14), CNP: 20.39 (+0.19), SNI: 67.13 (+0.99), AVID: 16.31 (+0.23), IMS: 28.71 (-0.57), PDVW: 44.98 (+0.47), P: 18.31 (-0.50), HNSN: 1.01 (+0.11), SSP: 21.73 (-0.04), DYN: 33.85 (+1.45), LOGI: 15.28 (-0.35), GRPN: 6.61 (unch), DATA: 110.09 (-2.57), MAC: 83.59 (+0.09), AN: 62.30 (-0.02)
Viveve Announces $12M Private Placement of Common Stock
Marketwired - Wed May 13, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that it has signed definitive agreements in connection with a private placement that will result in gross proceeds to Viveve of approximately $12 million. The common stock to be issued in the transaction will be issued at a per share purchase price of $0.37 for approximately 32.4 million shares. Stonepine Capital, L.P. is the lead subscriber in the offering and will receive an option to designate one director to the board. In addition to subscriptions received from other quality investors, approximately 25% of the gross proceeds will be raised from members of the Company's management, existing insiders and affiliates of insiders, including Alta Bioequities, L.P, 5AM Ventures II, L.P. and 5AM Co-Investors II, L.P.
Viveve Announces Distribution Partnership With Neo Asia PTE, Ltd
Marketwired - Wed Apr 22, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced the expansion of its commercial efforts into Singapore, Malaysia, Vietnam and Brunei in partnership with NeoAsia PTE, Ltd. ("NeoAsia"

, a distributor of medical devices based in Singapore. The partnership combines NeoAsia's expertise in introducing new technologies and providing exceptional service with Viveve's innovative product for treating vaginal laxity.
Viveve to Participate in the Master Investor 2015 Conference in London
Marketwired - Tue Apr 21, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, is pleased to announce that it will exhibit at the Master Investor 2015 conference to be held on Saturday April 25, 2015 at The Business Design Centre, 52 Upper Street, London N1 0QH. The Viveve booth number is 29 on the exhibit floor. For more information on registering and getting to the conference, please visit www.masterinvestor.co.uk.
Viveve Announces Distribution Partnership With Dalton Medical, B.V.
Marketwired - Thu Apr 09, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced a new distribution partnership with Dalton Medical, B.V. ("Dalton Medical"

, a distributor of medical devices based in Oosterhout, Netherlands. The agreement, which covers the Netherlands, Belgium and Luxembourg, combines Dalton Medical's strong presence in the medical device market throughout the region with Viveve's innovative product for treating vaginal laxity. The Viveve® Treatment is now available throughout the United Kingdom, Ireland, Spain, Netherlands, Belgium and Luxembourg.
Viveve Completes Enrollment in the VIVEVE I Clinical Trial
Marketwired - Tue Apr 07, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced the completion of patient enrollment in the VIVEVE I clinical study. The VIveve Treatment of the Vaginal Introitus to EValuate Efficacy study is the first randomized, blinded and sham-controlled trial designed to demonstrate the efficacy of the Viveve® Treatment versus a sham control procedure for the treatment of vaginal introital laxity.
Viveve Announces Distribution Partnership With Global DIA Solutions S.L. of Spain
Marketwired - Wed Apr 01, 7:28AM CDT
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced a new distribution partnership with Global DIA Solutions S.L. ("GDS"

, a distributor of medical devices based in Barcelona, Spain with offices in Madrid and Valencia. This partnership combines GDS's expertise in building new medical device markets throughout Spain with Viveve's innovative product for treating vaginal laxity. The Viveve® Treatment is now available throughout the United Kingdom, Ireland, and Spain.
Viveve Appoints James Atkinson Chief Business Officer/President
Marketwired - Mon Feb 09, 3:30PM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that James Atkinson has joined the company as Chief Business Officer and President. In this newly created position, Mr. Atkinson will provide strategic leadership in building the company's global distribution network, positioning Viveve for strong market expansion worldwide. In addition, he will serve as a member of Viveve's executive leadership team where he will contribute to the formulation and execution of the company's strategic vision.
STJ: 74.96 (+0.47)
Viveve Initiates the VIVEVE I Clinical Trial
Marketwired - Tue Dec 16, 7:28AM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that the first patient was successfully treated at the Allan Centre, in Calgary Canada, by Dr. Bruce Allan, a leading Canadian gynecologist. The VIVEVE I clinical study -- VIveve Treatment of the Vaginal Introitus to EValuate Efficacy is a randomized, blinded and sham-controlled trial designed to demonstrate the efficacy of the Viveve® Treatment versus a sham control procedure for the treatment of vaginal introital laxity.
Viveve Presentation Now Available for On-Demand Viewing
PR Newswire - Mon Dec 08, 7:29AM CST
Viveve Medical, Inc. (OTC QB: VIVMF) ("Viveve"

, the parent company to Viveve, Inc., a company focused on women's health, today announced that the December 4th presentation, is now available for on-demand viewing at VirtualInvestorConferences.com.
Viveve Announces Presentation at World Meeting in Paris
Marketwired - Wed Dec 03, 9:24AM CST
Viveve Medical, Inc. ("Viveve"

(OTCQB: VIVMF), a company focused on women's health, today announced that Dr. Michael Krychman, a medical advisor to the company, a world renowned specialist in sexual health and the Executive Director of The Southern California Center for Sexual Health and Survivorship, will present the Viveve® System as a non-invasive treatment for vaginal introital laxity to improve sexual function in adult females during the 20th World Congress in Obstetrics, Gynecology & Infertility, being held December 4th through the 7th in Paris.
Eight Companies Webcast Live to Investors, December 4th at VirtualInvestorConferences.com
PR Newswire - Tue Dec 02, 7:29AM CST
CEOs and top executives to take questions in real-time during formal roadshow presentations as well as meet and "chat" in virtual trade booths
SMLR: 3.36 (-0.20), CRBP: 4.00 (+0.10), ONVO: 4.54 (-0.03), CYTX: 0.66 (-0.02), IAG: 2.31 (-0.01)
Viveve to Webcast Live at VirtualInvestorConferences.com
PR Newswire - Mon Nov 24, 7:28AM CST
Company invites individual and institutional investors, as well as advisors to attend this interactive, real-time virtual investor conference